Results from the ... National Survey on Drug Use and Health PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Results from the ... National Survey on Drug Use and Health PDF full book. Access full book title Results from the ... National Survey on Drug Use and Health by National Survey on Drug Use and Health (U.S.). Download full books in PDF and EPUB format.
Author: National Survey on Drug Use and Health (U.S.)
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 320
Get Book Here
Book Description
Author: National Survey on Drug Use and Health (U.S.)
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 320
Get Book Here
Book Description
Author: Pratima Ramful Srivastava
Publisher: Springer Science & Business Media
ISBN: 3319024051
Category : Business & Economics
Languages : en
Pages : 178
Get Book Here
Book Description
Recreational drug policies and regulations are complex issues with many dimensions. This book attempts to answer several questions raised in current drug policy debates. Developing cost-effective drug programs and policies require a sound knowledge of drug users and their characteristics and the relationship across drugs. Who are the drug users? Can demographic factors help towards predicting drug usage? What sub-population groups should be targeted for drug campaigns and educational programs? Can a drug policy aimed at discouraging the use of one drug likely to affect the use of other drugs which are its economic substitutes or complements? What are the implications of drug use? Policymakers and researchers in the area of health and social development would find this book very useful.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309439124
Category : Social Science
Languages : en
Pages : 171
Get Book Here
Book Description
Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.
Author: Torsten Kolind
Publisher: SAGE
ISBN: 147394418X
Category : Medical
Languages : en
Pages : 844
Get Book Here
Book Description
With contributions from leading international academics across the social sciences, this accessible handbook takes a critical look at the key theories, disciplinary approaches, contemporary issues and debates in the field. · Part I Central Social Science Theories Drug and Alcohol Studies · Part II Pillars in Social Science Drug and Alcohol Studies · Part III Controversies and New Approaches in Social Science Drug and Alcohol Studies This Handbook is an excellent reference text for the growing number of academics, students, scientists and practitioners in the drug and alcohol studies community.
Author: Kenneth W. Clements
Publisher: Cambridge University Press
ISBN: 0521884950
Category : Business & Economics
Languages : en
Pages : 441
Get Book Here
Book Description
A fascinating analysis of a widely used, but little understood illicit drug.
Author: Tom Decorte
Publisher: Routledge
ISBN: 1134785216
Category : Social Science
Languages : en
Pages : 316
Get Book Here
Book Description
For the majority of its history, the cultivation of cannabis did not stand out, at least compared to the cultivation of other illegal plants. Cannabis plantations, like coca bush or opium poppy plantations, were typically large in size, grown by local farmers in a handful of developing (producing) countries, processed and then exported to industrial (consuming) nations. While cocaine and heroin are still produced in a handful of developing countries, cannabis cultivation is increasingly universal. From Europe to the Americas and Oceania, import substitution in cannabis markets has been noticed in almost every developed country around the world, with a notable aversion for discrimination. Geographical, technological, cultural and economic factors help to explain why (indoor and outdoor) domestic cultivation is well established, and why the nature and extent of cultivation varies so dramatically across the western, developed nations. As we start the second decade of the 21st century, the new cannabis industry continues to fascinate both casual and academic observers of the drug scene. Researchers around the world have become increasingly interested in the phenomenon, aiming to describe, and potentially explain, the rapid switch from importation to domestic production in their own countries. In bringing together some of the world's leading experts on cannabis cultivation this book contains sixteen chapters that take an interdisciplinary look at global trends in cannabis cultivation. It will serve as an exemplar for wider discussions of key theories and concepts relating to the spread not just of cannabis cultivation, but also of illegal markets more generally, the actors that operate within these markets and the policies and practices that are employed in response to developments within these markets.
Author: Thomas Babor
Publisher: Oxford University Press
ISBN: 0192550276
Category : Medical
Languages : en
Pages : 349
Get Book Here
Book Description
Illegal psychoactive substances and illicit prescription drugs are currently used on a daily basis all over the world. Affecting public health and social welfare, illicit drug use is linked to disease, disability, and social problems. Faced with an increase in usage, national and global policymakers are turning to addiction science for guidance on how to create evidence-based drug policy. Drug Policy and the Public Good is an objective analytical basis on which to build global drug policies. It presents the accumulated scientific knowledge on drug use in relation to policy development on a national and international level. By also revealing new epidemiological data on the global dimensions of drug misuse, it questions existing regulations and highlights the growing need for evidence-based, realistic, and coordinated drug policy. A critical review of cumulative scientific evidence, Drug Policy and the Public Good discusses four areas of drug policy; primary prevention programs in schools and other settings; supply reduction programs, including legal enforcement and drug interdiction; treatment interventions and harm reduction approaches; and control of the legal market through prescription drug regimes. In addition, it analyses the current state of global drug policy, and advocates improvements in the drafting of public health policy. Drug Policy and the Public Good is a global source of information and inspiration for policymakers involved in public health and social welfare. Presenting new research on illicit and prescription drug use, it is also an essential tool for academics, and a significant contribution to the translation of addiction research into effective drug policy.
Author:
Publisher:
ISBN:
Category : Drug abuse surveys
Languages : en
Pages : 422
Get Book Here
Book Description
Author: National Institute on Drug Abuse. Community Epidemiology Work Group
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages : 400
Get Book Here
Book Description
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309317258
Category : Medical
Languages : en
Pages : 269
Get Book Here
Book Description
Tobacco consumption continues to be the leading cause of preventable disease and death in the United States. The Food and Drug Administration (FDA) regulates the manufacture, distribution, and marketing of tobacco products - specifically cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco - to protect public health and reduce tobacco use in the United States. Given the strong social component inherent to tobacco use onset, cessation, and relapse, and given the heterogeneity of those social interactions, agent-based models have the potential to be an essential tool in assessing the effects of policies to control tobacco. Assessing the Use of Agent-Based Models for Tobacco Regulation describes the complex tobacco environment; discusses the usefulness of agent-based models to inform tobacco policy and regulation; presents an evaluation framework for policy-relevant agent-based models; examines the role and type of data needed to develop agent-based models for tobacco regulation; provides an assessment of the agent-based model developed for FDA; and offers strategies for using agent-based models to inform decision making in the future.
